(S (NP (NP (JJ Recent) (NNS events)) (VP (VBG leading) (PP (IN to) (NP (NP (DT the) (JJ worldwide) (NN pandemic)) (PP (IN of) (NP (NNP COVID) (HYPH -) (NNP 19))))))) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (JJ effective) (NN use)) (PP (IN of) (NP (JJ genomic) (NN sequencing) (NNS technologies)))) (S (VP (TO to) (VP (VB establish) (NP (NP (DT the) (JJ genetic) (NN sequence)) (PP (IN of) (NP (DT this) (NN virus))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NML (NNP COVID) (HYPH -) (CD 19)) (NN pandemic)) (VP (VBZ has) (VP (VBN demonstrated) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ computational) (NNS approaches)))) (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN of) (NP (DT this) (NN infection)))) (ADVP (RB rapidly))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (DT an) (JJ integrated) (NN approach)) (PP (IN to) (NP (NP (DT the) (NN study)) (PP (IN of) (NP (NP (DT the) (NN nsp1) (NN protein)) (PP (IN in) (NP (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP 1)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ plays) (NP (DT an) (JJ essential) (NN role)) (PP (IN in) (S (VP (VBG maintaining) (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ viral) (NNS proteins)))) (CC and) (NP (NP (NP (JJ further) (VBG disabling)) (NP (DT the) (NML (NN host) (NN protein)) (NN expression))) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (DT the) (NN host) (NN shutoff) (NN mechanism))))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (SBAR (S (NP (NP (CD three) (JJ independent) (NNS methods)) (PP (IN of) (S (VP (VBG evaluating) (NP (CD two) (JJ potential) (NN binding) (NNS sites)))))) (VP (VBD speculated) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NN host) (NN shutoff))) (PP (IN by) (NP (NN nsp1)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (NP (VBN combined) (NNS results)) (PP (IN from) (NP (NP (VBN computed) (NNS models)) (PP (IN of) (NP (NN nsp1))))) (, ,) (PP (IN with) (NP (NP (JJ deep) (NN mining)) (PP (IN of) (NP (NP (NP (DT all) (VBG existing) (NN protein) (NNS structures)) (-LRB- -LRB-) (VP (VBG using) (NP (NN PDBMine))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NML (VBG binding) (NN site)) (NN recognition)) (-LRB- -LRB-) (VP (VBG using) (NP (NN msTALI))) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (CD two) (NNS sites)) (VP (VBG consisting) (PP (IN of) (NP (NP (NNS residues)) (NP (NP (QP (CD 55) (HYPH -) (CD 59))) (CC and) (NP (QP (CD 73) (SYM -) (CD 80)))))))))))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (PRP$ our) (JJ preliminary) (NNS results)))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NNS residues)) (NP (CD 73) (SYM -) (CD 80))) (VP (VBP appear) (PP (IN as) (NP (NP (DT the) (NNS regions)) (SBAR (WHNP (WDT that)) (S (VP (VBP facilitate) (NP (NP (DT the) (JJ critical) (JJ initial) (NNS steps)) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN nsp1))))))))))))))) (. .))
(FRAG (S (PP (VBN Given) (NP (DT the) (NML (CD 90) (NN %)) (NN sequence)))) (FRAG (NP (NN identity)) (PP (IN between) (NP (NP (NN nsp1)) (PP (IN from) (NP (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP 1)) (CC and) (NP (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (CD 2)) (, ,) (NP (PRP we))))))) (NP (NN conjecture)) (NP (NP (DT the) (JJ same) (JJ critical) (NN initiation) (NN step)) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN COVID) (HYPH -) (CD 19)))))) (NP (NN nsp1))) (. .))
